The Ministry of Health and Community Protection has warned of a possible risk of cancer in patients using XR Belviq (locaserin), which is produced by Arena Pharmaceuticals, which is used for weight loss.
The ministry said in a circular issued to all health facilities, that there is no evidence to suggest that lorcaserin contributes to the risk of cancer, however, the U.S. Food and Drug Administration wanted to educate the public about this potential risk, and health care practitioners must consider whether the benefits of eating the substance Lorcaserin pharmacokinetics outweighs the potential risks when deciding on a description or follow-up of patients, and patients currently taking the drug should speak to their doctors about the possible increased risk of cancer.
In another circular, the Ministry warned about the safety reports of the medical device Segment Cuvette Reaction CH Atellica, produced by Siemens Healthcare Diagnostic Inc., as the manufacturer determined that about half of the percent of the products in this group ending with the operating number "17" or "18" may It has defects in the laboratory cup, allowing water from the water bath to contaminate the inside of the cap, knowing that the laboratory cup inside the affected slide is not affected in all situations.
The Ministry has determined the operating numbers, namely, N1503218, 1503918, N1526418, N1527518, N1530318, N1532318, and requested to inspect and dispose of the product if it is within the mentioned operations.